SIBO in Crohn's Disease: Symptoms, Diagnosis, and Treatment

If you have Crohn's disease and your bloating, gas, and diarrhea keep coming back even though your inflammatory markers look normal, there is a real chance that SIBO in Crohn's disease is behind your symptoms. Small intestinal bacterial overgrowth affects roughly one in three Crohn's patients (2), and because its symptoms so closely resemble an active flare, it is one of the most commonly missed diagnoses in our community.

Key Takeaways

• About 32% of Crohn's disease patients have SIBO - more than five times the rate seen in healthy individuals (2)
• SIBO symptoms closely mimic a Crohn's flare, which can lead to unnecessary steroid escalation when antibiotics are the appropriate treatment (4)
• The recommended diagnostic tool is a glucose or lactulose hydrogen breath test, a non-invasive procedure that takes two to three hours (1)
• Rifaximin 1200 mg/day for 10 days monthly over three months improved bloating in 59% of Crohn's patients in remission versus 19% of controls (5)
• Key risk factors include prior abdominal surgery, stricturing or penetrating disease, lower BMI, and proton pump inhibitor use (2, 3)

What Is SIBO and Why Are Crohn's Patients at Higher Risk?

Small intestinal bacterial overgrowth occurs when excessive bacteria colonize the small bowel, causing gastrointestinal symptoms such as bloating, diarrhea, and abdominal pain (1). Under normal conditions, the small intestine hosts relatively few bacteria compared to the colon - but in Crohn's patients, several disease-specific factors disrupt that balance.

Defining small intestinal bacterial overgrowth

The American College of Gastroenterology (ACG) defines SIBO as the presence of excessive bacteria in the small bowel that produces symptoms (1). These bacteria ferment carbohydrates that would normally be absorbed, generating hydrogen and methane gas and triggering the bloating, distension, and altered bowel habits that make daily life miserable. The bacteria can also interfere with fat and nutrient absorption, leading to deficiencies in vitamin B12, iron, and fat-soluble vitamins over time.

Why Crohn's disease creates the perfect conditions for SIBO

Crohn's disrupts almost every natural defense against bacterial overgrowth in the small intestine. Strictures and narrowed segments slow intestinal transit, giving bacteria time to settle in and multiply. Fistulae can create abnormal connections that allow colonic bacteria to travel upstream. Prior bowel surgery - especially ileocecal valve resection - removes the gate that normally separates the bacteria-rich colon from the cleaner small intestine. And the altered gut motility that many of us experience with Crohn's means the normal sweeping contractions (called the migrating motor complex) that clear bacteria between meals may not work as effectively.

The numbers tell the story clearly. A 2025 meta-analysis published in Frontiers in Medicine found that the pooled prevalence of SIBO in inflammatory bowel disease was 31.0%, and the odds of having SIBO were 5.25-fold higher than in healthy controls (2). Crohn's disease patients had an even higher prevalence at 32.2%, compared to 27.8% in ulcerative colitis (2). Understanding gut microbiome diversity and its role in Crohn's progression helps explain why this bacterial imbalance matters so much.

Why SIBO Symptoms Are So Easily Mistaken for a Crohn's Flare

SIBO and an active Crohn's flare share so many symptoms that even experienced gastroenterologists can struggle to tell them apart without testing. Recognizing this overlap is the first step toward getting the right treatment.

Overlapping symptoms

The classic SIBO symptom profile includes bloating, abdominal pain, distension, increased gas, watery diarrhea, unintentional weight loss, and fatigue (3). If that list sounds familiar, it should - these are the exact complaints that send most Crohn's patients reaching for their gastroenterologist's phone number, convinced a flare is starting.

A 2009 study published in BMC Gastroenterology examined this overlap directly. Klaus and colleagues found that Crohn's patients who tested positive for SIBO had an average of 5.9 bowel movements per day, compared to 3.7 in SIBO-negative patients - yet there was no correlation with Crohn's disease activity scores (4). In other words, their symptoms were driven by bacterial overgrowth, not by Crohn's inflammation.

Why this diagnostic confusion matters

When SIBO is mistaken for a flare, the treatment response goes in the wrong direction. Patients may be prescribed steroids, have their biologic dose escalated, or undergo unnecessary scoping - none of which will resolve symptoms caused by bacterial overgrowth. Meanwhile, the actual problem - treatable with a short course of antibiotics - goes unaddressed (4). This is why testing matters, and why normal inflammatory markers in the face of persistent symptoms should always raise the question: could this be SIBO?

Who Is Most at Risk? Predictors of SIBO in Crohn's

Not every Crohn's patient will develop SIBO, but certain factors significantly raise the odds. Understanding your personal risk profile can help you and your gastroenterologist decide when testing is warranted.

Disease-related risk factors

The 2025 meta-analysis identified several key predictors of SIBO in IBD patients: lower BMI, symptoms of bloating and flatulence, history of prior abdominal surgery, and stricturing or penetrating disease behavior (2). Each of these factors makes physiological sense. Strictures slow transit and create stagnant pools where bacteria thrive. Penetrating disease can form fistulae that bridge the colon and small intestine. And abdominal surgery - particularly ileocecal resection - removes the natural barrier between the bacterial ecosystems of the large and small bowel.

Patients with blind loops created during surgical anastomoses are at particularly high risk, as these dead-end segments become breeding grounds for bacterial overgrowth. Short bowel anatomy after extensive resection adds another layer of risk by reducing the total absorptive surface and altering motility patterns.

Lifestyle and treatment-related factors

Beyond disease-related anatomy, several modifiable and treatment-related factors can tip the scales toward SIBO. Proton pump inhibitors (PPIs), commonly used for reflux, reduce gastric acid - one of the body's first-line defenses against bacteria reaching the small intestine (3). Opioid pain medications slow gut motility, creating the stagnant environment that bacteria love. Even reduced physical activity, which many of us experience during flares or recovery periods, can slow the intestinal housekeeping waves that help keep bacterial counts in check.

It is important to remember that having Crohn's does not guarantee you will develop SIBO. Many patients with significant disease history never develop it. Testing is the only way to confirm - and the only way to avoid both over-treatment and under-treatment.

How SIBO Is Diagnosed: The Breath Test Explained

The good news about SIBO diagnosis is that the recommended test is non-invasive, widely available, and straightforward for patients. The not-so-good news is that it requires some preparation and patience.

Hydrogen and methane breath testing

The ACG 2020 guideline recommends glucose or lactulose hydrogen breath testing as the preferred diagnostic method for symptomatic patients suspected of having SIBO (1). Here is what to expect:

• Before the test: You will need to fast overnight (typically 12 hours). In the days before testing, your doctor will ask you to avoid antibiotics, probiotics, and fermentable foods that could skew the results. Some clinics provide a specific pre-test diet to follow for 24 to 48 hours.
• During the test: You provide a baseline breath sample, then drink a measured amount of a sugar solution (either glucose or lactulose). Over the next two to three hours, you give breath samples every 15 to 20 minutes.
• What gets measured: The lab measures hydrogen and methane in your breath. Bacteria in the small intestine ferment the sugar and produce these gases, which are absorbed into the bloodstream and exhaled. A significant rise above baseline within a defined time window indicates bacterial overgrowth.

For patients whose predominant symptom is constipation rather than diarrhea, methane testing is particularly important. Elevated methane levels point toward intestinal methanogen overgrowth (IMO), a related condition where archaea organisms produce methane that slows gut transit (1).

Limitations and gold standard comparison

Breath testing is practical but imperfect. False positives can occur in patients with rapid intestinal transit (the sugar reaches the colon before the testing window closes), and false negatives can happen if the overgrown bacteria do not produce hydrogen or methane. The historical gold standard - obtaining a fluid sample directly from the small intestine (jejunal aspirate culture) - is more definitive but requires an invasive endoscopic procedure and is rarely used outside of research settings (3).

For most Crohn's patients, breath testing strikes the right balance between accuracy and accessibility. If your results are borderline, your gastroenterologist may consider a therapeutic trial of antibiotics and evaluate your symptom response as an additional diagnostic clue.

Treatment Options: Antibiotics, Diet, and Addressing Root Causes

Treating SIBO effectively requires addressing both the overgrowth itself and the underlying Crohn's-related factors that allowed it to develop. A short-term fix without a long-term strategy is likely to lead to recurrence.

First-line antibiotic therapy

The ACG guideline suggests antibiotics for symptomatic SIBO patients to eradicate the overgrowth and resolve symptoms (1). The most commonly used first-line antibiotic is rifaximin (known by brand names such as Xifaxan), a gut-selective antibiotic that works locally in the intestine with minimal systemic absorption. A typical course is 550 mg three times daily for 14 days (1).

The evidence in Crohn's patients specifically is encouraging. A 2021 randomized trial by Tocia and colleagues, published in Medicine, tested rifaximin 1200 mg per day for 10 days each month over three months in Crohn's patients in remission who had IBS-like symptoms. The results were striking: 59% of the rifaximin group achieved adequate improvement in bloating (compared to 19% of controls), 54.5% had meaningful reduction in abdominal pain (vs. 21.4%), and 70.4% reported improved quality of life (vs. 21.4%) (5). As explored in our article on the impact of antibiotics on Crohn's disease, rifaximin has an interesting profile in IBD because of its gut-selective action and relatively mild side-effect profile.

One important reality to prepare for: SIBO recurrence is common. Studies suggest that a significant proportion of patients experience symptom return within months of completing a course. Some gastroenterologists use cycled or repeated antibiotic courses - for example, 10 to 14 days of rifaximin every month or every few months - to keep overgrowth in check while longer-term strategies take effect.

Dietary support and treating underlying Crohn's

Antibiotics address the bacterial overgrowth, but lasting improvement often requires treating the conditions that allowed SIBO to develop in the first place. For Crohn's patients, this means:

• Managing strictures and inflammation: If a stricture is creating stagnant segments, treating the underlying Crohn's with biologics, immunomodulators, or in some cases endoscopic dilation or surgery can reduce the structural environment that feeds SIBO.
• Dietary adjustments: Some patients find that a low-FODMAP-style eating pattern helps manage symptoms between antibiotic courses by reducing the fermentable carbohydrates that feed small intestinal bacteria. This is not a treatment for SIBO itself, but it can be a useful bridging strategy.
• Prokinetic agents: Your gastroenterologist may consider prokinetic medications that stimulate the migrating motor complex - the between-meal sweeping contractions that naturally clear bacteria from the small intestine. These are sometimes used as maintenance therapy after antibiotic treatment.
• Addressing nutrient deficiencies: SIBO-related malabsorption can deplete vitamin B12, iron, and fat-soluble vitamins (A, D, E, K). Testing for and treating these deficiencies is an important part of the full picture, especially for Crohn's patients who may already be at risk.

Living With SIBO and Crohn's: Practical Self-Advocacy

Getting SIBO diagnosed in the context of Crohn's disease often requires you to be your own best advocate. The overlap with flare symptoms means this diagnosis is easy to miss unless someone thinks to look for it.

How to bring SIBO up with your gastroenterologist

If you are experiencing persistent bloating, gas, and diarrhea despite normal inflammatory markers - your fecal calprotectin is low, your CRP is normal, and your last scope or MRI looked reassuring - it is worth asking your gastroenterologist specifically about SIBO testing. You might say something like: "My Crohn's seems controlled on paper, but I am still having a lot of bloating and loose stools. Could we do a breath test to check for SIBO?"

This is especially worth pursuing if you have had ileocecal valve resection or other abdominal surgery, if you have known strictures, or if your symptoms worsened after starting a proton pump inhibitor. Along with SIBO, bile acid diarrhea is another commonly missed cause of persistent diarrhea in Crohn's patients in remission - and some patients have both.

Tracking symptoms to distinguish SIBO from a flare

Keeping a simple symptom diary can help you and your care team tease apart SIBO from a flare. Note:

• Timing of bloating: SIBO-related bloating tends to worsen progressively after meals, especially meals containing fermentable carbohydrates (bread, pasta, legumes, certain fruits)
• Response to antibiotics vs. steroids: If a previous course of antibiotics improved your symptoms more than steroids did, that is a strong signal worth sharing with your doctor
• Dietary triggers: SIBO symptoms often have clearer food-related patterns than flare symptoms

Remember that SIBO does not mean your Crohn's is uncontrolled. It can occur in clinical remission, and finding it is actually good news - because it means your symptoms have a treatable, identifiable cause beyond your underlying disease. Many patients in our community report that treating SIBO brought the most noticeable improvement in their daily quality of life in years.

One final caution: avoid the temptation to self-treat with leftover antibiotics, herbal antimicrobials, or unproven supplements marketed for SIBO online. Testing first is essential because misdirected treatment wastes time, money, and potentially exposes you to side effects for no benefit. Let the breath test guide the plan.

Frequently Asked Questions

What is SIBO and how is it connected to Crohn's disease?

SIBO (small intestinal bacterial overgrowth) is a condition where excessive bacteria colonize the small bowel, causing bloating, diarrhea, and abdominal pain. Crohn's patients are at dramatically higher risk - about 32% prevalence compared to roughly 6% in healthy individuals - because strictures, prior surgery, and altered motility create an environment where bacteria can thrive (1, 2).

Can SIBO cause symptoms that look exactly like a Crohn's flare?

Yes. SIBO produces bloating, diarrhea, abdominal pain, fatigue, and weight loss - the same symptoms as an active flare. One study found SIBO-positive Crohn's patients had 5.9 bowel movements per day versus 3.7 in SIBO-negative patients, with no correlation to disease activity (4). Normal inflammatory markers alongside persistent symptoms are a key clue to consider SIBO.

How is the SIBO breath test done and is it uncomfortable?

The breath test is non-invasive. After an overnight fast, you drink a sugar solution (glucose or lactulose) and provide breath samples every 15 to 20 minutes over two to three hours. The lab measures hydrogen and methane gas produced by bacteria. Most patients find it boring rather than uncomfortable - the main challenge is the prep diet and the fasting beforehand (1).

What is the main treatment for SIBO in Crohn's patients?

The first-line treatment is a course of rifaximin, a gut-selective antibiotic typically prescribed at 550 mg three times daily for 14 days. In Crohn's patients in remission, a cycled regimen of rifaximin 1200 mg/day for 10 days monthly produced significant improvement in bloating (59% vs. 19%) and quality of life (70.4% vs. 21.4%) (1, 5).

Does SIBO keep coming back after treatment?

Recurrence is common, especially if the underlying conditions driving it - strictures, altered anatomy from surgery, or slow motility - are still present. Many gastroenterologists use cycled antibiotic courses and address the root causes (managing strictures, adjusting medications, using prokinetics) to reduce recurrence rates over time.

Should I try a special diet to treat SIBO?

Diet alone does not eradicate SIBO, but a low-FODMAP-style eating pattern can help manage symptoms between antibiotic courses by reducing the fermentable carbohydrates that bacteria feed on. Always discuss dietary changes with your healthcare team, as overly restrictive diets can worsen the nutritional deficiencies that Crohn's patients are already prone to.

What should I ask my doctor if I suspect SIBO?

Ask specifically for a hydrogen and methane breath test, especially if your inflammatory markers (CRP, fecal calprotectin) are normal but you are still experiencing bloating, gas, and diarrhea. Mention any risk factors you have: prior abdominal surgery, known strictures, PPI use, or symptoms that worsen after carbohydrate-heavy meals.

References

1. Pimentel, M., Saad, R.J., Long, M.D., Rao, S.S.C. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. American Journal of Gastroenterology, 2020;115(2):165-178. View on PubMed
2. Feng, Y., Hu, Y., Zhang, X. Prevalence and predictors of small intestinal bacterial overgrowth in inflammatory bowel disease: a meta-analysis. Frontiers in Medicine, January 2025. Read study
3. Cleveland Clinic. Small Intestinal Bacterial Overgrowth (SIBO). 2024. Read article
4. Klaus, J., et al. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease. BMC Gastroenterology, 2009;9:61. Read study
5. Tocia, C., et al. Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms? Medicine, 2021;100(1):e24059. Read study